ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,100Medicare Part D Prescriptions Filled, Including Refills

Rank: 216 out of 682

$445K Total Retail Price of All Prescriptions

Rank: 325 out of 682

469 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,659 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SIMVASTATIN 602 492 1 4
LISINOPRIL 559 424 2 2
AMLODIPINE BESYLATE 359 323 3 6
OMEPRAZOLE 346 257 4 5
HYDROCODONE-ACETAMINOPHEN 336 235 S3 5 1
GABAPENTIN 303 224 6 9
FUROSEMIDE 287 268 7 7
LEVOTHYROXINE SODIUM 258 237 8 3
METFORMIN HCL 249 179 9 8
METOPROLOL TARTRATE 239 192 10 10
METOPROLOL SUCCINATE 215 183 11 16
ROPINIROLE HCL 194 155 12 71
WARFARIN SODIUM 190 168 13 13
HYDROCHLOROTHIAZIDE 190 166 13 12
AZITHROMYCIN 163 139 15 39
ISOSORBIDE MONONITRATE ER 159 117 16 31
ALLOPURINOL 159 120 16 32
GLIMEPIRIDE 156 126 18 43
CARVEDILOL 150 110 19 23
DICLOFENAC SODIUM 142 99 20 107
AMOX TR-POTASSIUM CLAVULANATE 138 106 21 110
CITALOPRAM HBR 136 73 22 17
PRAVASTATIN SODIUM 131 112 23 15
POTASSIUM CHLORIDE 129 86 24 14
RANITIDINE HCL 127 91 25 28
TAMSULOSIN HCL 120 92 26 33
BUMETANIDE 117 88 27 115
ATORVASTATIN CALCIUM 117 99 27 11
MELOXICAM 109 101 29 27
TRAMADOL HCL 108 87 30 26
CLOPIDOGREL 102 79 31 25
LOVASTATIN 101 72 32 66
LOSARTAN POTASSIUM 96 71 33 20
ALENDRONATE SODIUM 93 88 34 37
KLOR-CON M20 92 88 35 67
DOXAZOSIN MESYLATE 90 70 36 96
ATENOLOL 89 89 37 18
PLAVIX 83 68 38 35
PANTOPRAZOLE SODIUM 78 40 39 29
CRESTOR 71 54 40 22
SPIRIVA 67 48 41 49
CLONIDINE HCL 67 57 41 48
OXYBUTYNIN CHLORIDE 67 57 41 173
ZOLPIDEM TARTRATE 65 40 44 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 62 44 34
TRAZODONE HCL 63 36 46 38
BENAZEPRIL HCL 61 61 47 89
TIZANIDINE HCL 60 32 48 83
CIPROFLOXACIN HCL 60 47 48 58
HYDRALAZINE HCL 57 49 50 74
PAROXETINE HCL 57 44 50 53
GLIPIZIDE 55 48 52 61
NEXIUM 54 28 53 19
DOXYCYCLINE HYCLATE 52 42 54 137
COMBIVENT 50 37 55 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.